4-Phenyltetrahydropyrido[4,3-b]indoles (1) and 5-phenylhexahydroazepino [4,5-b]indoles (2) were obtained by cyclisation reactions starting from N-3-indolylmethylephedrines and N-3-indolylethylnorephedrines respectively, using conc.sulfuric acid (for 1) and PPA (for 2), the latter cyclisation yielding to the racemised azepinoindoles (2), whereas the previous one reacts to 1 in a remarkably stereoselective manner with double inversion = retention of its configuration, obviously going through a spirocyclic intermediate.Compounds with selectivity to dopamine receptor subtypes can be achieved through rigidification of indolyl-and phenylalkylamines.E.g. the well-known SCH-23390 2 and the recently presented LE 300 3 are molecular combinations of tryptamine and 2-phenylethylamine in a constrained conformation and they proved to be potent and selective D 1 /D 5 -antagonist.Having in mind these structures we focussed our efforts on the synthesis of other partially rigidified indolyl-phenyl-alkylamines such as 1 and 2. Because of the stereogenic centres being of crucial importance for the receptor affinities (see SCH-23390) we decided to use the ephedrine enantiomers, as well as the pseudoephedrine enantiomers as synthons for the phenylethylamine part.
No takes yet. Share an insight, caveat, or question.
Lehmann et al. (2001) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: